IDO1 and diabetes mellitus: Moreover, the proinflammatory cytokine, IFN-γ can modulate the activity of rate-limiting enzyme of KP, the IDO1, therefore the dysregulation of the KP might be involved in the pathogenesis of CAD and/or its risk factors, including diabetes mellitus (133).